Company intelligence / Profile preview

Mega Medica Pharmaceuticals

Indonesia

Ownership: Private
Development stage: Other

Overview

Mega Medica Pharmaceuticals is an Indonesian pharmaceutical company specializing in wound care solutions and oral albumin-based nutraceuticals derived from Channa striata. The company's portfolio includes commercialized products for wound healing, post-surgical recovery, and maternal/child health. There is no publicly available clinical trial data.

Therapeutic areas: OtherDermatologyWomen's Health
Modalities: Oral albuminNutraceuticalsTopical wound care products
Industry: Food & Nutrition

Beyond the preview

Go deeper on Mega Medica Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mega Medica Pharmaceuticals.

Explore the full profile